Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: Jacques Tootight who wrote (637)	3/22/1998 9:58:00 AM
From: MisterED	Read Replies (2) \| Respond to of 9523

D'Arcy, everything you are saying makes sense if Viagra delivers and is what it is cranked up to be. My problem is that I think Muse is a more efficient and reliable cure for ED and will be the winner in the long run from what I read and hear. Maybe I put my money on the wrong horse. I can't wait to see how Viagra will perform in the market place. But one thing is for sure, Pfizer does not know either and they have proven over and over again that they are worried about Muse. The Vivus management freely refers to Viagra, but Pfizer is very careful not to ever mention Muse although it is already approved by the FDA and doing well. All they mention are the other uncomfortable injections, but not the Muse transurinal painless drug pellets. I have personally tried the Muse and know. Hopefully I can soon try the Viagra, if they get the approval.